T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Quest Diagnostics
DGX
$26.2B
| $208M | 0.03% |
1,692,947
+567,417
| +50% | +$74.7M |
|
352
Altria Group
MO
$107B
| $207M | 0.03% |
5,114,533
+323,168
| +7% | +$14.1M |
|
353
ON Semiconductor
ON
$32.4B
| $206M | 0.03% |
3,309,872
+2,163,419
| +189% | +$139M |
|
354
Otis Worldwide
OTIS
$28.2B
| $206M | 0.03% |
3,227,959
-571,016
| -15% | -$41.8M |
|
355
Insmed
INSM
$28.9B
| $206M | 0.03% |
9,548,247
-6,674,376
| -41% | -$160M |
|
356
AT&T
T
$166B
| $205M | 0.03% |
13,374,039
-2,046,707
| -13% | -$37.2M |
|
|
PARA
357
DELISTED
Paramount Global Class B
PARA
| $205M | 0.03% |
10,747,843
+1,226,884
| +13% | +$29.5M |
|
358
Lam Research
LRCX
$408B
| $204M | 0.03% |
5,581,040
-6,667,040
| -54% | -$297M |
|
359
ICICI Bank
IBN
$107B
| $204M | 0.03% |
9,706,293
+206,416
| +2% | +$4.36M |
|
360
Microchip Technology
MCHP
$43.1B
| $203M | 0.03% |
3,330,239
-22,673,092
| -87% | -$1.49B |
|
361
Affirm
AFRM
$24.6B
| $199M | 0.03% |
10,548,549
-801,746
| -7% | -$21M |
|
362
C.H. Robinson
CHRW
$17.1B
| $198M | 0.03% |
2,055,299
-385,085
| -16% | -$41.4M |
|
363
Kemper
KMPR
$1.56B
| $198M | 0.03% |
4,796,802
-3,241,185
| -40% | -$152M |
|
364
Ultragenyx Pharmaceutical
RARE
$2.65B
| $197M | 0.03% |
4,756,956
-6,023,200
| -56% | -$310M |
|
365
Penumbra
PEN
$12.9B
| $195M | 0.03% |
1,029,095
-202,034
| -16% | -$32.4M |
|
366
Southern Copper
SCCO
$165B
| $194M | 0.03% |
4,721,591
+158,575
| +3% | +$6.93M |
|
367
Corebridge Financial
CRBG
$15.1B
| $194M | 0.03% |
+9,831,688
| New | +$202M |
|
368
Zoom
ZM
$30.8B
| $193M | 0.03% |
2,617,499
-3,070,270
| -54% | -$292M |
|
|
EXAS
369
DELISTED
Exact Sciences
EXAS
| $189M | 0.03% |
5,814,177
-9,608,207
| -62% | -$396M |
|
370
CNA Financial
CNA
$13.7B
| $186M | 0.03% |
5,051,088
-1,175,566
| -19% | -$47.9M |
|
|
EA
371
DELISTED
Electronic Arts
EA
| $186M | 0.03% |
1,609,257
+1,177,415
| +273% | +$149M |
|
372
Dentsply Sirona
XRAY
$2.27B
| $186M | 0.03% |
6,553,344
-3,434,653
| -34% | -$117M |
|
373
Bunge Global
BG
$21.5B
| $185M | 0.03% |
2,242,259
-2,197,660
| -49% | -$205M |
|
374
Workday
WDAY
$43.3B
| $185M | 0.03% |
1,213,751
-335,930
| -22% | -$52.6M |
|
375
American Homes 4 Rent
AMH
$12.2B
| $184M | 0.03% |
5,602,489
+726,426
| +15% | +$26.2M |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.